Clinical TrialsSearch results
Number of results: 989
Completed
- Single and Multiple Dose Study of MK-7480 in Healthy Japanese Participants
- Nonalcoholic fatty liver disease
- Yoshitsugu Hiroyuki
- 2024-05-22
Completed
- Single Administration study of Bomedemstat (MK-3543) in Healthy Japanese
- Essential thrombocythaemia
- Fujita Tomoko
- 2023-11-25
Completed
- Sequential combination therapy with CHOP and mogamulizumab in untreated primary ATLL patients
- adult T-cell leukemia-lymphoma
- Kato Koji
- 2019-03-18
Completed
- Safety, tolerability and efficacy study of OAV101 administered intrathecally to participants 2 to < 18 years of age with spinal muscular atrophy (SMA) who have discontinued treatment with nusinersen (Spinraza) or risdiplam (Evrysdi)
- Spinal muscular atrophy
- Maruyama Hideki
- 2023-01-22
Completed
- Safety and Immunogenicity of V116 in Vaccine-Experienced Adults
- Pneumococcal infection prevention
- Tanaka Yoshiyuki
- 2022-07-08
Completed
- Research for COVID-19 vaccine among lung cancer patients undergoing chemotherapy
- COVID-19
- Nakashima Kei
- 2021-05-18
Completed
- Repeated-dose study for oral A4250 in healthy Japanese adult subject
- Progressive Familial Intrahepatic Cholestasis
- Achiwa Hiroyuki
- 2022-09-03
Completed
- Randomized controlled study of GnRH antagonist monotherapy and CAB with GnRH agonist plus bicalutamide for patients with metastatic prostate cancer.(KYUCOG-1401).
- metastatic prostate cancer
- Naito Seiji
- 2019-03-11
Completed
- Placebo-controlled, multicenter, double-blind, randomized, parallel-group, comparative study to evaluate the safety and immunogenicity of KD-414, a vaccine against COVID-19, in healthy adults aged >=20 years to <65 years, and healthy elderly subjects aged >=65 years.
- COVID-19
- Matsumoto Takayuki
- 2021-03-03
Completed
- PhaseII study of DOCETAXEL plus RAMUCIRUMAB for NSCLC with brain metastasis
- Non-small cell lung carcinoma
- Uchino Junji
- 2019-03-15